Circulating tumor cells PD‐L1 expression detection and correlation of therapeutic efficacy of immune checkpoint inhibition in advanced non‐small‐cell lung cancer

INTRODUCTION: This study investigated whether programmed death‐ligand 1 (PD‐L1) expression of circulating tumor cells (CTCs) in peripheral blood can serve as a predictive biomarker for immunotherapy efficacy in patients with advanced non‐small‐cell lung cancer (NSCLC). METHODS: We employed a negativ...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Qing, Liu, Xiangning, Li, Ji, Tong, Bing, Xu, Yan, Chen, Minjiang, Liu, Xiaoyan, Gao, Xiaoxing, Shi, Yuequan, Zhao, Jing, Zhong, Wei, Wang, Mengzhao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9925337/
https://www.ncbi.nlm.nih.gov/pubmed/36630992
http://dx.doi.org/10.1111/1759-7714.14767

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9925337/
https://www.ncbi.nlm.nih.gov/pubmed/36630992
http://dx.doi.org/10.1111/1759-7714.14767

Ejemplares similares